Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions

Psychological Medicine

Volumn 28, Issue 3, 1998, Pages 721-729

  Linden, M ^a   Bar T ^a   Geiselmann, B ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

ADULT; AGED; ARTICLE; ATTITUDE; BEHAVIOR; DEMOGRAPHY; DRUG DEPENDENCE; EDUCATION; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PERCEPTION; PERSONALITY; PRESCRIPTION; PRIMARY MEDICAL CARE; WITHDRAWAL SYNDROME;

AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ATTITUDE TO HEALTH; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NEUROLOGIC EXAMINATION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT CARE TEAM; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TREATMENT REFUSAL;

EID: 2642682454     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291798006734     Document Type: Article

References (43)

1. Ashton, H. (1994). The treatment of benzodiazepine dependence. Addiction 89, 1535-1541.
2. Ballenger, J. C., Pecknold, J., Rickels, K. & Sellers, E. M. (1993). Medication discontinuation in panic disorder. Journal of Clinical Psychiatry 54, 15-21.
3. Balter, M. B., Mannheimer, D. I. & Mellinger, G. D. (1984). A cross-national comparison of antianxiety/sedative drug use. Current Medical Research Opinion 8, 5-20.
4. Başoǧlu, M., Marks, I. M., Kiliç, C., Brewin, C. R. & Swinson, R. P. (1994). Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry 164, 652-659.
5. Baum, J. (1991). Long-term benzodiazepine use. Journal of Family Practice 32, 127.
6. Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez Craig, M. & Sykora, K. (1986). Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315, 854-859.
7. Del Rio, M. C. & Alvarez, F. J. (1996). How benzodiazepines are prescribed in a primary health care setting in Spain. Thérapie 51, 185-189.
8. Farnsworth, M. (1990). Benzodiazepine dependence: misconceptions and facts. Journal of Family Practice 32, 127-128.
9. Geiselmann, B. & Linden, M. (1991). Prescription and intake patterns in long-term and ultra long-term benzodiazepine treatment in primary-care practice. Pharmacopsychiatry 24, 55-61.
10. Geiselmann, B., Linden, M. & Sachs Ericsson, N. (1989). Benzodiazepine prescriptions and therapist non-compliance. European Archives of Psychiatric and Neurological Sciences 239, 180-187.
11. Goldberg, D. & Blackwell, B. (1970). Psychiatric illness in general practice. British Medical Journal ii, 439-443.
12. Goldberg, D. & Hiller, V. F. (1979). A scaled version of the General Health Questionnaire. Psychological Medicine 9, 139-145.
13. Golombok, S., Higgit, A., Fonagy, P., Dodds, S., Saper, J. & Lader, M. (1987). A follow-up study of patients treated for benzodiazepine dependence. British Journal of Medical Psychology 60, 141-149.
14. Holm, L., Berman, H. & Borg, S. (1982). Personality characteristics of patients with exclusive abuse of sedative-hypnotic drugs. Psychological Reports 51, 899-903.
15. Holton, A., Riley, P. & Tyrer, P. (1992). Factors predicting long-term outcome after chronic benzodiazepine therapy. Journal of Affective Disorders 24, 245-252.
16. Joughin, N., Tata, P., Collins, M., Hooper, C. & Falkowski, J. (1991). Inpatient withdrawal from long-term benzodiazepine use. British Journal of Addiction 86, 449-455.
17. Lader, M. (1994). Anxiolytic drugs: dependence, addition and abuse. European Neuropsychopharmacology 4, 85-91.
18. Lilja, J. & Larsson, S. (1994). Social Pharmacology: Unresolved critical issues. International Journal of the Addictions 29, 1647-1737.
19. Linden, M. (1989). Indikationen und Komplikationen bei der Benzodiazepin-Behandlung in der Praxis. Zeitschrift für Allgemeinmedizin 65, 293-298.
20. Linden, M. (1994). Therapeutic standards in psychopharmacology and medical decision-making. Pharmacopsychiatry 27, 41-45.
21. Lohse, M. J. & Müller-Oerlinghausen, B. (1995). Psychopharmaka. In Arzneiverordnungsreport 95 (ed. U. Schwabe and D. Pfaffrath), pp. 360-377. Gustav Fischer: Stuttgart.
22. Lyndon, R. W. & Russell, J. D. (1988). Benzodiazepine use in a rural general practice population. Australian and New Zealand Journal of Psychiatry 22, 293-298.
23. Magrini, N., Vaccheri, A., Parma, E., D'Alessandro, R., Bottoni, A., Occhionero, M. & Montanaro, N. (1996). Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. European Journal of Clinical Pharmacology 50, 19-25.
24. Murphy, S. M. & Tyrer, P. (1991). A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry 158, 511-516.
25. Nicholas, D. & Hammond, S. M. (1992). Personality characteristics of long-term benzodiazepine users. Personality and Individual Differences 13, 221-223.
26. Pariente, P., Lépine, J. P. & Lellouche, J. (1992). Self-reported psychotropic drug-use and associated factors in a French community sample. Psychological Medicine 22, 181-190.
27. Poser, W. & Poser, S. (1986). Abusus und Abhängigkeit von Benzodiazepinen. Internist 27, 738-745.
28. Rickels, K., Schweizer, E., Case, W. G. & Garcia Espana, F. (1988). Benzodiazepine dependence, withdrawal severity, and clinical outcome: effects of personality. Psychopharmacology Bulletin 27, 415-420.
29. Rickels, K., Case, W. G., Schweizer, E. & Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines. Effects of abrupt discontinuation. Archives of General Psychiatry 47, 899-907.
30. Rickels, K., Case, W. G., Schweizer, E., Garcia Espana, F. & Fridman, R. (1991). Long-term benzodiazepine users 3 years after participation in a discontinuation program. American Journal of Psychiatry 148, 757-761.
31. Romach, M. K., Busto, U. E., Sobell, L. C., Sobell, M. B., Somer, G. R. & Sellers, E. M. (1991). Long-term alprazolam use: abuse, dependence or treatment? Psychopharmacology Bulletin 27, 391-395.
32. Schweizer, E., Rickels, K., Case, W. G. & Greenblatt, D. J. (1990). Long-term use of benzodiazepines. Effects of gradual taper. Archives of General Psychiatry 47, 908-915.
33. Sellers, E. M., Ciraulo, D. A., Dupont, R. L., Griffiths, R. R., Kosten, T. R., Romach, M. K. & Woody, G. E. (1993). Alprazolam and benzodiazepine dependence. Journal of Clinical Psychiatry 54, 64-75.
34. Simon, G. E., VonKorff, M., Barlow, W., Pabiniak, C. & Wagner, E. (1996). Predictors of chronic benzodiazepine use in a health maintenance organization sample. Journal of Clinical Epidemiology 49, 1067-1073.
35. SPSS, Inc. (1992). SPSS Users Guide. 5.02. SPSS Inc.: Chicago.
36. Tyrer, P. (1993). Benzodiazepine dependence: a shadowy diagnosis. Biochemical Society Symposium 59, 107-119.
37. Tyrer, P., Rutherford, D. & Huggett, T. (1981). Benzodiazepine withdrawal symptoms and propanolol. Lancet i, 520-522.
38. Tyrer, P., Owen, R. & Dawling, S. (1983). Gradual withdrawal of diazepam after long-term therapy. Lancet i, 1402-1406.
39. WHO-programme on Substance Abuse (1996). Rational Use of Benzodiazepines. WHO: Geneva.
40. Wilms, H. U. & Linden, M. (1992). Die Patientenperspektive in der Langzeitbehandlung. In Die jahrelange Behandlung mit Psychopharmaka (ed. H. Helmchen and M. Linden), pp. 205-214. Walter de Gruyter: Berlin.
41. Wolf, B. & Griffiths, R. R. (1991). Physical Dependence on Benzodiazepines: differences within the class. Drug and Alcohol Dependence 29, 153-156.
42. Woods, J. H., Katz, J. L. & Winger, G. (1995). Abuse and therapeutic use of benzodiazepines and benzodiazepine-like drugs. In Psychopharmacology: The Fourth Generation of Progress (ed. F. E. Bloom and D. J. Kupfer), pp. 1777-1791. Raven Press: New York.
43. Wright, N., Caplan, R. & Payne, S. (1994). Community survey of long-term daytime use of benzodiazepines. British Medical Journal 309, 27-28.